Castilia Life Sciences LLP has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011
HIKAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Castilia Life Sciences LLP has submitted a disclosure to the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This pertains to a report on an acquisition made by relying on an exemption provided under Regulation 10. The full details such as the number of shares acquired, the price, and the resulting shareholding are not available in the headline. Regulation 10 exemptions typically apply to acquisitions that would otherwise attract the open offer requirement under the takeover code.
For retail shareholders, this indicates a change in the shareholding pattern of Hikal Limited, though the financial impact on the stock price is unlikely to be significant unless the acquisition is material in size. Investors should review the detailed disclosure to understand the size and nature of the acquisition.